OMRON Healthcare Surpasses 50 Million Nebulizers Sold
November 28, 2025OMRON Healthcare Co., Ltd., today announced that cumulative sales of its nebulizers have surpassed 50 million units.
An Important Notice from OMRON Healthcare, Inc. We have recently become aware of online scammers selling counterfeit products that appear to be from OMRON, but they are not legitimate. These fraudulent products can pose risks to your health and may not deliver the quality or performance you expect from OMRON. To protect yourself, please ensure you are purchasing OMRON products only from reputable, authorized resellers. Your health and safety are our top priority, and we are committed to providing you with trusted, high-quality products that meet the highest clinical standards of accuracy.
OMRON Healthcare Co., Ltd., today announced that cumulative sales of its nebulizers have surpassed 50 million units.
Expert judges determining the best of the best in healthcare innovation recognized OMRON Healthcare for its blood pressure monitors with AI-powered AFib detection
Guideline Emphasis on Earlier Treatment to Reduce Health, Dementia Risks Boosts Urgency to Keep Closer Watch on Blood Pressure
Heart health leader OMRON Healthcare today issued an urgent health message across the U.S. to raise public awareness of rapidly increasing risks and rising mortality rates associated with arrythmias such as atrial fibrillation (AFib), heart failure, and heart disease from long-term high blood pressure, as identified in new research.
Number one doctor and pharmacist-recommended blood pressure monitor brand introduces blood pressure monitors with OMRON Intellisense™ AFib
Intellisense AFib Technology Able to Detect Possible Atrial Fibrillation with Every Measurement; May 17 Marks World Hypertension Day during May Measurement Month